Expression of ITPR3 is reduced in many cholestatic diseases such as bile duct obstruction, biliary atresia, primary biliary cholangitis, and primary sclerosing cholangitis, resulting in diminished calcium signaling and calcium-mediated bicarbonate secretion (189). Here, ITPR3 is linked to cholestasis.